February 8, 2022
WILMINGTON, Del. – DuPont (NYSE:DD) – DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of < 1 week. DuPont’s bioprocessing solutions enable sophisticated purifications and separations for therapeutics and diagnostics, with brands such as DuPont™ AMBERCHROM™ and [...]
Hunt for new IP for the next generation of novel agrochemicals
February 8, 2022
Globachem renews contract with Cresset Discovery Cambridge, UK - Cresset Discovery, provider of contract consulting for early phase discovery, has been appointed by Globachem, who specialize in developing and marketing high quality crop protection products, to upskill their in-house team and assist them in developing the next generation of novel agrochemicals. Agrochemicals, which include pesticides and fertilizers, facilitate higher yields [...]
February 8, 2022
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe C2i to integrate Twist’s library preparation kits into minimal residual disease workflow NEW YORK & SOUTH SAN FRANCISCO, Calif. -- C2i Genomics, a cancer intelligence company, and Twist Bioscience [...]
February 8, 2022
Norms and standards are an important catalyst for scaling innovations. They define technological milestones and pave the way for innovative ideas to succeed in the marketplace. The IEEE’s mission is to maximize this leverage for private and public companies, a leverage that is often insufficiently exploited. Based on extensive research, interviews, and analysis, the IEEE [...]
February 8, 2022
Norms and standards are an important catalyst for scaling innovations. They define technological milestones and pave the way for innovative ideas to succeed in the marketplace. The IEEE’s mission is to maximize this leverage for private and public companies, a leverage that is often insufficiently exploited. Based on extensive research, interviews, and analysis, the IEEE [...]
Sartorius completes acquisition of Novasep’s chromatography division
February 8, 2022
Göttingen Sales revenue forecast for 2022 updated due to acquisition The life science group Sartorius announced today that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasep chromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission. The transaction had already been agreed upon at the [...]
New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis
February 8, 2022
Thermo Fisher Scientific expands Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers CARLSBAD, Calif. -- Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis,is an important tool for improving clinical research and advancing scientific discovery. To further enable customers’ cutting-edge research in areas such as gene editing and infectious disease, [...]
INTEGRA increases global turnover by 46 %
February 8, 2022
INTEGRA Biosciences has reported considerable growth for over 10 years – averaging 18 percent per annum – and more than doubling in the previous two years. The company grew by 73 percent in 2020, and has followed this with a 46 percent increase in turnover in 2021, reaching 191 million Swiss Francs. The life sciences [...]
Element Biosciences Closes Acquisition of Loop Genomics
February 8, 2022
Element Biosciences will offer both short-read and long-read sequencing on a common platform. Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced that the company has closed its acquisition of Loop Genomics, a long-read solutions company that enables short-read sequencers to obtain long-range information. Loop Genomics' Chief Executive Officer and Founder, Tuval [...]
February 8, 2022
The agreement combines industry-leading technologies, enabling single cell selection and genome sequencing, and supports the development of intact tissue sample analysis Together these technologies are designed to deliver breakthrough insights into in situ cellular heterogeneity to drive disease research, diagnostic and drug development, and treatment decisions DURHAM, N.C. -- BioSkryb Genomics, a leader of single-cell [...]
